William Blair downgrades Enfusion (ENFN) to a Hold
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
OneSpaWorld FY2025 EPS Forecast Lowered by William Blair
Research analysts at William Blair dropped their FY2025 earnings estimates for shares of OneSpaWorld in a research report issued on Monday, January 13th. William Blair analyst S. Zackfia now ...
Morningstar1mon
William Blair International Growth I
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
bovnews6h
Procept Biorobotics Corp (PRCT) Stock: A Deeper Look at Its True Potential
Procept Biorobotics Corp (PRCT) stock saw a decline, ending the day at $76.02 which represents a decrease of $-2.82 or -3.58% from the prior close of $78.84. The stock opened at $79.26 and touched a ...
William Blair Brokers Raise Earnings Estimates for Certara
William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...
FierceBiotech3d
Neumora's dig into phase 3 depression data disappoints analysts
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
bovnews4h
What’s Fueling Generation Bio Co (GBIO) Stock’s -61.35% Loss Below Its 200-Day SMA?
On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...
Yahoo Finance11d
William Blair Names Stewart Licudi Head of European Investment Banking
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
Denali Therapeutics’ (DNLI) Outperform Rating Reiterated at William Blair
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...